• Zak Mir interview with Patrick Southon, CEO of Gaming Realms

    August 27, 2019 | Posted by

    Zak Mir interviews Patrick Southon, CEO of Gaming Realms https://zakmir.com/wp-content/uploads/2019/08/Gaming-Realms-Interview.m4a Key points discussed: Overview of the business and expectations for new licensing focus. Relax Gaming and Scientific Games distribution agreements. Closing the valuation gap with industry peers. Plans to further penetrate the growing US market. Potential for a dividend payment. Expectations for the rest of […]

  • Argo Blockchain – New Agreement to Significantly Expand Mining Capacity

    August 20, 2019 | Posted by

    By Richard Gill, CFA Crypto miner Argo Blockchain (ARB) has entered into a new agreement with GPU.one to increase its supply to clean electricity by 357%, from 14MW to 64MW, at its two data centres in Quebec and its new data centres in Eastern Canada. The agreement is for three years from 25th June 2019, […]

  • Gaming Realms – New game launched in association with gaming industry giant  

    August 14, 2019 | Posted by

      By Richard Gill, CFA In a brief statement, Gaming Realms (GMR), the developer and licensor of real money, mobile-focused gaming content, has announced the launch of new game MONOPOLY Slingo. The game launched on 6th August and has been developed in collaboration with Monopoly’s owner, the NASDAQ listed games and entertainment giant Hasbro, Inc.  It […]

  • Five new Mid Cap Buy calls – TEVA (US), ENDP (US), KIE, MTRO & INTU

    August 10, 2019 | Posted by

    By Richard Jennings Clear warning upfront – each of these companies carry risk. They are unloved, oversold and resolutely out of favour! This very situation in investment is however the backdrop that creates extreme value – the fundamental tenet of risk v reward remains as true today as it ever was. Precisely because of these […]

  • Acasti Pharmaceuticals update – market finally wakes up to the potential implications of Phase 3 trials of CaPre

    July 28, 2019 | Posted by

    It has been quite the month for holders of Acasti Pharmaceuticals as the chart below pays testimony to. The stock has risen from just over $1 to a peak of $2.50 in recent days. Full background coverage by us can be found on the stock HERE. Acasti is one of our largest positions and was […]

Loading More